Fundraising Fox

Canaan Partners2026 Investments

8 investments dated 2026 · listed companies and verified rows first · show all

Alphina Therapeuticsalphinatx.comFeb 2026

Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.

BiotechNew Haven, US

Barbara Fox(Executive Officer, Director)Nicholas J Galli(Executive Officer, Director)Kevin L. Rakin(Executive Officer, Director)Stanley Choy(Executive Officer)Ranjit Bindra(Director)

Board seatColleen Cuffaro· per SEC Form D

Co-investorsConnecticut InnovationsHighCape CapitalOUP (Osage University Partners)

Notable FinanceMay 2026SEC filingmedium confidence

Stamford, US

Leigh Stephenson Browne(Executive Officer)Amy Malone(Executive Officer)Ryan Gillette(Executive Officer)Eugene Didenko(Executive Officer)Austin Lane(Executive Officer, Director)

BoardClare Tokheim(Director)

Board seatLaura Chau· per SEC Form D · $2M raise · filed Jul 2026

Portal Space Systemsportalsystems.spaceMar 2026SEC filingmedium confidence

Portal Space Systems develops advanced spacecraft, including its flagship Supernova vehicle, designed for high delta-v maneuverability and multi-orbit operations in cislunar space.

Deep TechHardwareSpace TechWashington, US

Jeffery Thornburg(Executive Officer, Director, Promoter)Ian Vorbach(Director)inPrashaanth Ravindran(Director)in

Board seatRayfe Gaspar-Asaoka· per SEC Form D · $72.4M raise · filed Mar 2026

Co-investorsAlleyCorpBooz Allen VenturesFUSEGeodesic CapitalIceNineTFX Capital+5 more

Qlaris Bioqlaris.bioJun 2026

Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.

BiotechMedical DevicesDedham, US

Thurein Htoo(Executive Officer, Director)Fred Guerard(President & Chief Executive Officer)Barbara Wirostko(Executive Officer)

BoardRonald M. Hunt(Director)Andrew Danielson(Director)

Board seatWende Hutton· per SEC Form D

Co-investorsabrdn plcCorrelation VenturesMayo Clinic VenturesNew Leaf Venture Partners

Solstice OncologyFeb 2026SEC filingmedium confidence

BiotechBoston, US

David Feltquate(Executive Officer)Maiken Keson-Brookes(Executive Officer)CAROLINE LOEW(Executive Officer, Director, Promoter)

BoardANDREW LEVIN(Director)EMILY MINKOW(Director)in

Board seatJulie Grant· per SEC Form D · $298.4M raise · filed Mar 2026

Co-investorsRA Capital

Replicantreplicant.comin𝕏Jul 2026

Replicant builds AI Agents that handle customer service conversations across voice, chat, and SMS, using a company's existing conversation data to resolve specific workflows.

AI & Machine LearningEnterprise SoftwareSaaS

Gadi Shamia(CEO and Co-Founder)inBenjamin Gleitzman(CTO and Co-Founder)in

Co-investorsAtomicOmega Venture PartnersInsight PartnersNewView CapitalNorwest Venture PartnersSalesforce Ventures+2 more

SageOxsageox.aiMay 2026 · $15M

SageOx builds a team-memory platform that captures decisions, discussions, and AI agent sessions and makes that context available to both people and AI assistants.

AI & Machine LearningDeveloper ToolsFuture of WorkSaaSSeattle, US

Ajit Banerjee(Founder)inMilkana Brace(Founder)inRyan Snodgrass(Founder)in

Co-investorsFounders' Co-opPioneer Square Labs

Telittelit.comin𝕏Jan 2026 · $51.5M

Telit designs and manufactures telecommunications terminal equipment and M2M (machine-to-machine) modules for industrial and IoT applications.

AI & Machine LearningEnterprise SoftwareHardwareIoTBoca Raton, US

Co-investors83NorthYL VenturesZeev Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.